Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
This article compares index fund choices for retirement in 2024, focusing on S&P 500 vs Total Market performance and cost considerations.
24,938 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
If you had $1,000 to put into a single stock this July, MercadoLibre could stand out for growth potential and a robus...
AI-driven models flag XRP as the most likely to post the biggest gains in the second half of 2026, even as Bitcoin an...
As markets wobble in early 2026, preferred shares matter for investors seeking steady income and lower drama than gro...
Bitcoin surged toward $71k and then cooled near $70k as geopolitical headlines about Iran dominated market sentiment,...
Fed chair Powell kept policy steady as he hailed resilience in the U.S. economy, while warning that inflation and ene...
As crypto markets shift into a new cycle, investors wonder where will chainlink (link) fit. This guide breaks down LI...
A new wave of proposals aims to tighten how decentralized finance operates in the U.S. Senate. These clarity amendmen...
Glamsterdam targets a mid-2026 mainnet upgrade that aims to ease congestion and boost Ethereum’s throughput. Analysts...
Nu Holdings approves a $1 billion share buyback, triggering a stock jump that investors will watch closely. Here’s wh...
Oracle stock dips despite a swelling backlog. This guide explains what backlog means, why the stock reacts, and how i...
In morning trading, Tesla sinks about 5% while Lucid edges higher and Rivian drifts, signaling a diverging path for t...